
Loading, please wait...

Loading, please wait...

India continues to battle a high tuberculosis burden according to the Global TB Report 2025. Consequently, Molecular TB Diagnostics have emerged as the new standard of care across the country. These tests offer far greater accuracy than traditional smear microscopy. Smear microscopy often missed one in two cases due to its low sensitivity. Therefore, rapid molecular platforms are now essential for early and accurate detection.
Molecular TB Diagnostics like Truenat and GeneXpert provide rapid and automated results. They detect Mycobacterium tuberculosis and identify resistance to rifampicin within two hours. India’s National Tuberculosis Elimination Programme now utilizes these tools as frontline tests. Specifically, the Truenat platform serves as a point-of-care solution in primary health centers. Furthermore, these tests are cost-effective at government facilities, costing between Rs 600 and Rs 800. Currently, about 45% of TB centers use these upfront molecular tests. However, scaling this technology to all centers remains a major priority for the government.
Traditional diagnosis typically requires a sputum sample for testing. Unfortunately, many patients, especially children and the elderly, struggle to produce sputum. New innovations from Indian firms like Molbio Diagnostics solve this issue. They utilize tongue swabs for easier sample collection while maintaining high accuracy. The World Health Organization recently recommended these near-point-of-care tests for pilot introduction. Additionally, ultra-portable digital X-rays help identify asymptomatic carriers who may not visit clinics. Artificial intelligence screens these X-rays to find potential cases instantly. Then, molecular tests confirm the final diagnosis. This combined approach significantly strengthens India’s goal to eliminate tuberculosis.
Q1: What are the benefits of molecular tests over traditional microscopy?
Molecular tests provide much higher sensitivity, detecting cases that microscopy misses. They also identify drug resistance in a single step, which is crucial for starting correct treatment immediately.
Q2: Why are tongue swabs being introduced for TB testing?
Tongue swabs are easier to collect than sputum, especially for patients who cannot cough up samples. This makes testing more accessible at the point of care and improves case finding.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India is shifting from smear microscopy to molecular diagnostics like Truenat and tongue swabs to improve TB detection rates and tackle drug resistance....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today